Member Info for trillsg

I've been pinged btw and bored 5hi tless, just in case anyone was wondering about my amount of posts on here.

Oh and to add, income from it coming back to the parent companies Deepverge and China Resources.
Chesh has experienced this scenario, hopefully he can expand on this.

IMO DG12, MW and CR will make a 'single entity' as previously mentioned by Gerry and IPO on the Hong Kong stock exchange. CR have a history of doing that. Initially I thought that was a negative but after reading posts from the likes of Gidget, it isn't. Free share in the new company for those that hold.

DG12, a bit back I owned shares in Sepura, they basically sold walkie talkies to the police and other emergency services, it was bought by the Chinese, unbelievable! If they can do that they can do anything.

It's a possibility Stu but hope it doesn't happen just yet. They'd be getting a bargain even at double mcap. We're just getting started, all the hard work has been done we just need to wait for the snowball to start rolling.

Not sure how to interpret the below smeeno. Are the first 200 the retro fits before a completely new unit, designed for the first time buyers? Yes £45 mill is pennies compared to the cost to the economy if we're faced with this again.
Next 12 Months In Detail
Designed with further development to include mass manufacturing solution
development and initial batch build of the system.
? Project key phases
? Project timeline
? 2021 Aug - Dec - Version 2 - 100+ units with motorised optical
alignment
? 2022 - Jan - Mar - Version 3 - 100+ units with auto chip / flow
cell feed
? 2022 - April - Mass Manufacture up to 200 pm - Integrated
hardware and software design

Eventually they'll ramp up to production of 200 MicrotoxPD's p/m. With the U.K having 9000 sewage treatment plants that contract would take years of production. £50k was for a Microtox CTM, I believe, how much now with the new tech added is anyone's guess. To quote smeeno, "£5k p/a for consumables and monitoring" the figures are astronomical!

It's nailed on we're in negotiations with governments. Question is which ones and how many?

Of course, nice one Smeeno, makes perfect sense. Will be ideal when moving into the US market.

Ogilvy is a New York City-based British advertising, marketing, and public relations agency.

https://www.adforum.com/agency/5066/clients/ogilvy

Details on the launch of the Skin Trust Club Android app and marketing campaign to commence in September engaging the skills of a, soon to be announced, top global media agency.

Any guesses as to who?

https://www.youtube.com/watch?v=i7Jx5-k0chI

I do believe they are Gidget. The big money is in the reoccurring consumables and monitoring cost.

Extremely happy with that! Did I hear/read it right, "planning to manufacture 200 MicrotoxPD per month"?
Well done Gerry and all the team.

60,000 Skin Trust Club home test kits per month at even £100 would generate a revenue of £70mil p/a. This alone is incredible. Looking forward to the AGM

Almost there. For those not sure of our connection with the posts below.
https://www.deepverge.com/microtox-bt-evaluation-of-sars-cov-2-from-breath-test-with-clinical-samples/
The joint development program of work on the PBM-HALE™ breath condensate device from PulmoBioMed is ongoing using multiplex bio-marker binding agents to analyse breath for 40 other diseases which include cancer, neurodegenerative, respiratory and metabolic conditions.

https://newsroom.northumbria.ac.uk/pressreleases/multi-million-pound-boost-for-north-east-company-creation-3118401
Northumbria’s latest spinout company, PulmoBioMed, was founded by Associate Professor of Cellular and Molecular Sciences, Dr Sterghios Moschos. The creation of the medtech company, whose lead product for collecting breath samples could revolutionise diagnosis of a range of diseases, including Covid-19, was supported by Northern Accelerator. Read more about PulmoBioMed and its innovative aerosol collecting device, PBM-Hale™,

Research progress on quality assurance of genuine Chinese medicinal in Sichuan. Feb 2021

Quality assessment technology and quality assurance of Sichuan GCM
GCM pharmacology was first proposed to objectively describe the drug effects of GCM, scientifically explain the related mechanism, explore the standards and methods based on biological effects and clinical efficacy to offer scientific evidence for drug property theory, pharmacological mechanism, and clinical treatment. A function of the Microtox (micro-toxic) technology with independent intellectual property rights is to carry out pharmacological and bio-quality evaluation technology research on Sichuan GCM's extracts. The objective is to realize standardization, speedy, quantitative characterization of biological effect (toxic) value, toxic dose–effect curve, as well as biological fingerprints of CM, and set up a new bio-control model and assessment system closely related to clinical efficacy, revealing the complex properties like diverse components, various targets, multiple effects of CM, in an overall view. The system provides ample data and scientific support for CM's quality control and safety supervision .
https://cmjournal.biomedcentral.com/articles/10.1186/s13020-021-00428-z

https://www.devdiscourse.com/article/health/1648868-jal-shakti-minister-shekhawat-reviews-jal-jeevan-mission
WHO has launched updated Guidelines for Recreational Water Quality, as the northern hemisphere summer reaches its peak and beaches, lakes and riversides are likely to see the return of visitors after months spent close to home amid COVID restrictions.

The guidelines, which should be applied alongside COVID-19 prevention measures, outline health-based water quality targets and best practices for monitoring and surveillance, pollution control and communication approaches such as predictive models to let users know in real-time when it is safe to go in the water.

Just to see a blue day is a great day regardless of how small. Tides turned? 2 trading days until the AGM, looking forward to it.

Long story Hutchy mate but decided to delete that tweet, not for CVRG reasons.

Just noticed this. Good to see you back. Respect for the way you departed after obviously selling. No drama, deramping or coming back to criticise the company. Just stopped posting, like it should be done.